Global Substance Abuse Treatment Market, By Type (Alcohol, Opioids, Tobacco/nicotine, Cocaine, Marijuana, Methamphetamines, Other illicit drugs), By Treatment Type (Opioid, Nicotine, Alcohol, Tobacco ,Others), By Age Group (Adolescents, Adults, Geriatric)
Global Substance Abuse Treatment Market, By Type (Alcohol, Opioids, Tobacco/nicotine, Cocaine, Marijuana, Methamphetamines, Other illicit drugs), By Treatment Type (Opioid, Nicotine, Alcohol, Tobacco ,Others), By Age Group (Adolescents, Adults, Geriatric), By Treatment Setting (Outpatient Treatment, Inpatient Treatment Residential Treatment Facilities, Detoxification Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Global substance abuse treatment market was valued US$ 11.8 Bn in 2023 and is expected to reach US$ 22.8 Bn by 2031 exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.
Figure 1. Global Substance Abuse Treatment Market Share (%), By Region, 2023
Substance abuse treatment refers to programs and activities that are aimed at managing substance dependence and support long-term sobriety and recovery. Substance abuse disorder which is also known as addiction, involves the compulsive or uncontrollable use of harmful and addictive substances despite their negative impact. Common substances of abuse include alcohol, opioids, cannabis, cocaine, and methamphetamines. Some key signs of substance abuse disorder include the inability to reduce intake, experiencing cravings, and having withdrawal symptoms when not using. Those suffering from addiction often experience impaired control, social problems, risky use, and sometimes even physical dependence. Substance abuse treatment aims to address the biological, psychological, social, and behavioral aspects of addiction through therapeutic interventions, counseling, medication, and community support programs. The rise in substance abuse rates globally is fueling demand for effective treatment options.
Market Dynamics:
Global substance abuse treatment market is driven by the rising prevalence of substance abuse disorders, increasing awareness regarding treatment availability, favorable regulations and reimbursement policies, and the launch of novel medication-assisted treatment products. However, the market growth can be restrained by social stigmas that are associated with addiction, lack of access to treatment facilities in low-income regions, and non-compliance issues with treatment protocols. The development of digital therapeutic solutions, integrated care models, targeted therapies for specific addictions, and expansion to emerging markets present key opportunities for the market players. Geographically, North America dominates the market due to advanced healthcare infrastructure and awareness. However, the Asia Pacific region is expected to offer lucrative growth prospects during the forecast period.
Key Features of the Study:
This report provides an in-depth analysis of the global substance abuse treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024–2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global substance abuse treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Indivior PLC, Pfizer, Inc., Johnson & Johnson Inc., Alkermes., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Inc., Par Pharmaceutical, Inc., USWM, LLC, Valeant Pharmaceuticals, Greenyard Pharmaceutical Ltd. Cipla Health Limited. Perrigo, Haleon Group of Companies, Ventus Medical, Glenmark and other prominent players.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global substance abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global substance abuse treatment market.
Detailed Segmentation:
Global Substance Abuse Treatment Market, By Type
Alcohol
Opioids (e.g., heroin, prescription painkillers)
Tobacco/nicotine
Cocaine
Marijuana
Methamphetamines
Other illicit drugs (Benzodiazepines, etc.)
Global Substance Abuse Treatment Market, By Treatment Type
Opioid
Methadone
Buprenorphine
Extended-release naltrexone
Lofexidine
Nicotine
Nicotine replacement therapies (available as a patch, inhaler, or gum)
Bupropion
Varenicline
Alcohol
Naltrexone
Disulfiram
Acamprosate
Tobacco
Clonidine
Nortriptyline
Others (Topiramate, Modafinil, etc.)
Global Substance Abuse Treatment Market, By Age Group
Adolescents
Adults
Geriatric
Global Substance Abuse Treatment Market, By Treatment Setting
Outpatient Treatment
Outpatient Clinics
Private Practices
Inpatient Treatment
Rehabilitation Centers
Hospitals
Residential Treatment Facilities
Detoxification Centers
Global Substance Abuse Treatment Market, By Region
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Top Companies in the Global Substance Abuse Treatment Market:
Indivior PLC
Pfizer, Inc.
Johnson & Johnson Inc.
Mallinckrodt Pharmaceuticals
Teva Pharmaceuticals, Inc.
Par Pharmaceutical, Inc.
USWM, LLC
Valeant Pharmaceuticals
Greenyard Pharmaceutical Ltd
Cipla Health Limited
Perrigo
Haleon Group of Companies
Ventus Medical
Glenmark
Other Prominent Players
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Type
Market Snippet, By Treatment Type
Market Snippet, By Age Group
Market Snippet, By Treatment Setting
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Increasing consumption of drugs and alcohol
Growing support from government and NGOs
Restraints
Social stigma associated with substance dependence
Lack of adequate rehabilitation facilities
Opportunities
Untapped markets in developing countries
Company Market Share Analysis
Key Highlights
Market Trends
PEST Analysis
PORTER’s Analysis
Recent Product Approvals/Launches
Mergers, Acquisitions, and Collaborations
4. Global Substance Abuse Treatment Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Substance Abuse Treatment Market, By Type, 2019-2031, (US$ Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Alcohol
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Opioids (e.g., heroin, prescription painkillers)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Tobacco/nicotine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Cocaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Marijuana
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Methamphetamines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Other illicit drugs (Benzodiazepines, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
6. Global Substance Abuse Treatment Market, By Treatment Type, 2019-2031, (US$ Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Opioid
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Methadone
Buprenorphine
Extended-release naltrexone
Lofexidine
Nicotine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Nicotine replacement therapies (available as a patch, inhaler, or gum)
Bupropion
Varenicline
Alcohol
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Naltrexone
Disulfiram
Acamprosate
Tobacco
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Clonidine
Nortriptyline
Others (Topiramate, Modafinil, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
7. Global Substance Abuse Treatment Market, By Age Group, 2019-2031, (US$ Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Adolescents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Adults
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Geriatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
8. Global Substance Abuse Treatment Market, By Treatment Setting, 2019-2031, (US$ Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Outpatient Treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Outpatient Clinics
Private Practices
Inpatient Treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Rehabilitation Centers
Hospitals
Residential Treatment Facilities
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Detoxification Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
9. Global Substance Abuse Treatment Market, By Region, 2019-2031, (US$ Bn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2019 – 2031
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Bn)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Company Profile
Indivior PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Pfizer, Inc.
Johnson & Johnson Inc.
Mallinckrodt Pharmaceuticals
Teva Pharmaceuticals, Inc.
Par Pharmaceutical, Inc.
USWM, LLC
Valeant Pharmaceuticals
Greenyard Pharmaceutical Ltd
Cipla Health Limited
Perrigo
Haleon Group of Companies
Ventus Medical
Glenmark
Other Prominent Players
Analyst Views
11. Section
References
Research Methodology
About us
*Browse 44 market data tables and 43 figures on “Global Substance Abuse Treatment Market” - Global forecast to 2031